BPC-157 and TB-500 are two synthetic peptides known for their research potential in the field of tissue regeneration, healing, and protection. In this combined form, they are being studied primarily for their synergistic effects on muscles, tendons, blood vessels, and the nervous system.
Contents
5mg BPC-157 + 5mg TB-500
Concentration (test)
BPC-157: 5.87 mg / TB-500: 5.12 mg
Packaging
Glass bottle with cap
Storage
2–8 °C, away from light
Molecular formula
C62H98N16O22 + C212H350N56O78S
Molecular weight
1419.535 g·mol⁻¹ + 4963.37 g·mol⁻¹
IUPAC name
Body Protective Compound + Thymosin Beta-4 Acetate
CAS number
137525-51-0 / 77591-33-4
Other names
BPC157, PL 14736, TB500, thymosin beta-4
In laboratory studies, BPC-157 and TB-500 are associated with research in areas such as:
- regeneration of muscles, tendons, ligaments and blood vessels,
- angiogenesis and wound healing,
- reducing inflammation and oxidative stress,
- protection of the digestive tract and nerve cells,
- restoration of damaged tissues after injuries or surgeries.
This content is for educational purposes only. It is not a recommendation for human use. The substance is intended for laboratory research only.
What is BPC-157 + TB-500?
It is a combination of two peptides: BPC-157 – a stable fragment of a protein from gastric secretion and TB-500 – a fragment of thymosin beta-4. Both substances are tested in the field of tissue regeneration, and in combination an enhanced synergistic effect is expected.
How the combination works
BPC-157 promotes angiogenesis, mucosal and nervous system repair, while TB-500 stimulates actin formation and muscle and ligament repair. The combination is being studied in cases of soft tissue damage, inflammatory processes or neurological diseases.
Researched effects and interesting facts
-
Regeneration: synergistic support for the recovery of muscles, tendons and nerve endings
-
Angiogenesis: supporting the vascular network and blood circulation
-
Anti-inflammatory effects: reduction of local and systemic inflammation
-
Gastroprotective action: restoration of damaged mucous membranes and prevention of ulcers
-
Neuroprotection: protecting and supporting mitochondrial activity in neurons
Dosage in studies
The values listed are derived solely from research studies and are not intended for real-world use outside of a laboratory environment.
-
Dose: 200 – 800 μg (BPC‑157), 2 – 5 mg (TB‑500)
-
Form: injectable (sc/im), sometimes topical
-
Frequency: daily or weekly
-
Duration: 2 – 6 weeks
Possible side effects
- Mild irritation at the injection site
- Rare headache, fatigue
- There are no systemic toxic effects at the doses tested.
Resources
- Sikiric, P. et al. – BPC‑157: Healing and biological roles (2018)
- Goldstein, AL et al. – Thymosin beta‑4 in tissue repair (2005)
- Chang, CH et al. – Peptides in tendon healing (2011)
- Wang, Y. et al. – Muscle regeneration peptides review (2017)
This article is for informational purposes only. It does not constitute a recommendation or solicitation for use. The information provided is a summary of existing scientific literature and is for educational purposes only.
Sale
Sale
Sale
